New Service Protocol for Attention Deficit/Hyperactivity Disorder With Comorbidity: A Randomized Waitlist-controlled (ADHD+)
ADHD
About this trial
This is an interventional treatment trial for ADHD
Eligibility Criteria
Inclusion Criteria:
- children, adolescent and young adults (Aged 6-15);
- have sufficient proficiency in Chinese to understand verbal instructions and give informed consent;
- clinically significant mild to moderate ADHD syndromes requiring intervention;
- without learning disabilities and intelligence quotient (IQ) score not lower than 70;
- are "more likely to commit time in the projects" for reasons such as intention to treat and
- receiving the New ADHD+ service.
Exclusion Criteria:
- known diagnosis of intellectual disability;
- not reaching syndrome diagnostic threshold for ADHD;
- already receiving medical interventions / treatments at Hospital Authority (HA) and/or private sector;
- known psychiatric diagnosis (stabilized diagnosis and treatment);
- current or active suicidal ideation or attempts;
- have received structured psychosocial intervention for more than 3 contact hours (for waitlist group); and
- refusal to give consent.
Sites / Locations
- University of Hong KongRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Other
Group-based ADHD+ Treatment
wait-list control group
This randomized controlled trial (RCT) will run in multi-sites including 5 non-governmental organizations (NGOs) in Hong Kong. Core treatment components are developed by an expert group comprised of psychiatrists and clinical psychologists including internet use/addiction intervention, cognitive training, etc. The main intervention lasts for 3 months, and the booster intervention lasts for another 3 months.
For participants in the waiting list control group, they will receive 1-3 hours psychoeducation during the 3 months wait period. Appropriate intervention will be offered after the treatment group.